Clinical Trial Update: Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients

View source ↗

Summary

This clinical trial update notes the addition of azathioprine and hydroxyurea preconditioning to an alemtuzumab/TBI regimen in matched-sibling HSCT for adult si…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Azathioprine (azathioprine)
• HYDROXYUREA (Hydroxyurea)
• Total Body Irradiation

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Sickle Cell Disease | Status: COMPLETED